The global oncology mice models market is set to record a market value of US$ 390.3 Mn in 2022, with an estimated growth rate of 6% over the decade. Syngeneic tumor mice models are expected to reach a market value of US$ 219.3 Mn, which accounts for more than 50% of the overall oncology mice models market.
The global market for oncology mice models is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of cancer, the growing demand for new cancer therapies, and the increasing adoption of mice models in cancer research.
One of the key drivers of the oncology mice models market is the increasing prevalence of cancer. As the global population grows and ages, the incidence of cancer is expected to increase. This is driving demand for research into new therapies and treatments for cancer, which in turn is driving demand for oncology mice models.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33046
Surge in research of oncology drugs in the past decade has resulted in the generation of a large number of target molecules that need to undergo preclinical and clinical trials for approval. This will help to boost the growth of the market.
In September 2021, Harbour BioMed announced IND approval for phase II trial of Anti-FcRn Batoclimab in chronic inflammatory demyelinating polyneuropathy, in China.
The Jackson Laboratory
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Crown Bioscience Inc. (JSR Corporation).
Applied stem cells
Ingenious Targeting Laboratory
PolyGene – Transgenic mice model company
Champions Oncology Inc
Laboratory Corporation of America Holdings
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33046
Key Takeaways from Market Study
Syngeneic tumor mice models contributed the highest revenue share of 56.2% in 2021 in the global market.
The end user segment was dominated by contract research organizations with nearly 1/3 revenue share in 2021.
North America led the global market with nearly 48.6% value share in 2021.
“The global oncology mice models market is expected to witness significant growth due to development of immuno-oncology combination drugs therapy,” says a Persistence Market Research analyst.
Some of the leading suppliers of mice models are The Jackson Laboratory, Charles River, Taconic Biosciences, Shanghai Model organism, and Envigo amongst others. Key market players are focusing on acquisitions, collaborations, and product launches to increase their revenues across geographies.
In February 2021, Charles River acquired Cognate Bioservices to expand its cell and gene therapy programs.
In January 2022, Taconic Biosciences announced the launch of the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse.
In October 2021, The Jackson Laboratory announced the acquisition of Charles River Laboratories Japan.
In September 2021, Envigo announced a collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse model.
Get up to 20% off on Immediate Purchase @ https://www.persistencemarketresearch.com/checkout/33046
Robotic Surgery Market
Veterinary Teleradiology Market
Dental Radiology Equipment Market
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
This release was published on openPR.